ORDER A TEST Log In Contact Us
Hero Background

Our Platform /// Multi-omics

High throughput solutions provide comprehensive datasets for consumer, academic, and research needs

We offer a broad range of technologies to support your high throughput needs, from genotyping to methylation to NGS.

Contact Us

Our Solutions

  1. Genotyping

    We have a wide portfolio of genotyping solutions to fit the needs of small and high volume data projects.
  2. Methylation

    We have robust methylation solutions with an optimized workflow for high quality data.
  3. NGS

    Our lab has Illumina’s MiSeqs, NextSeqs and NovaSeqs to support all your sequencing needs.

Genotyping

Our wide portfolio of genotyping solutions fit the needs of small and high volume data projects:

Illumina

  • Medium to high throughput volumes
  • Multiple arrays for GWAS sample analysis
  • Arrays and boosters for a wide variety of testing such as PGx

Thermofisher

  • Medium to high throughput volumes
  • Enables GWAS, PGx and Gene Expression analysis
  • 24, 96 sample formats
image description

Methylation

We have robust methylation solutions with an optimized workflow for high quality data.
  • Extensive experience running Illumina Infinium EPIC 850k chips at high throughput
  • Capability to run customized methylation arrays to provide a range of medium to large data sets
  • Assay can provide data for research applications such as methylation profiling and biological age calculations
  • Supports data generation for EWAS analysis
image description

NGS

Our lab has Illumina’s MiSeqs, NextSeqs and NovaSeqs to support all your sequencing needs.

Low Pass Whole Genome Sequencing

  • Cost effective to obtain large quantities of data
  • Combined with imputation across the whole genome
  • Low coverage combined with the NovaSeq enables very high throughput

Metagenomics

  • Supports microbiome analysis through shotgun metagenomics or 16s analysis.
  • 16S rRNA sequencing analyzes the prokaryotic 16S ribosomal RNA gene (1500 bp), which contains 9 variable regions (species-specific)
  • Enables interrogation and monitoring aspects of variable regions on the bacteria.
  • Excellent resource for gut microbiome monitoring or ongoing research
image description

Our differentiators

  • Strong partnership

    and collaboration to find tailored solutions for successful outcomes

  • High quality data

    across multi-omic platforms

  • Fast turnaround time

    on average 10 days from batch creation

  • Wide range of technology

    from genotyping and sequencing to metagenomics and methylation

Our Impact

It is great to have a familiar genomic service provider in Atlanta. [Tempus Multi-omics] brings a lot of experience and has provided responsive and cost-effective methylation and gene expression profiling for us on multiple occasions.

Dr. Greg Gibson, Professor and Director, Center for Integrative Genomics, Georgia Institute of Technology

Our Impact

The UC Athena project is utilizing [Tempus Multi-omics]’s  expert capability to screen for genome variants in the context of cancer.

Dr. Laura van’t Veer, Professor and Endowed Chair in Cancer Research, Department of Laboratory Medicine, UCSF

Our Impact

We were attracted to [Tempus Multi-omics] because of their outstanding quality and service oriented approach as well as their know-how in molecular genetic technologies. The unique partnership with [Tempus Multi-omics] will allow us to expand our comprehensive suite of services that have successfully supported the pharma market for nine years. Through this collaboration, we will be able to better serve all of our customers in the US, with the unmatched quality and value-added services that we have established over the past nine years.

Dr. Thomas Henkel, CEO of Targos

Our Impact

We are very pleased to be working with [Tempus Multi-omics]. They are a leading provider of genetic technologies, with advanced capabilities, including next generation forensic profiling solutions, and most importantly excellent service This combination is critical to advancing the future of forensic investigation. We have already achieved success in several of recent projects that we have completed together.

Dr. Laurence Rubin, CEO of Identitas

Our Impact

[Tempus Multi-omics] is a leader in molecular genetic technologies, and is particularly known for its outstanding delivery of service.

Don Rule, CEO of Translational Software

Product and company names are trademarks of their respective holders. Use of them does not imply affiliation or endorsement.

Partner with us

With a broad range of technologies and assays, we have the solutions you need.